Bristol-Myers Squibb to Take Part in the UBS Global Healthcare Conference
14 Mai 2019 - 12:59PM
Business Wire
Bristol-Myers Squibb Company (NYSE: BMY) will take part in a
fireside chat at the UBS Global Healthcare Conference on Tuesday,
May 21, 2019, in New York. Giovanni Caforio, M.D., chairman and
chief executive officer will answer questions at 2:30 p.m. ET.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. Materials
related to the presentation will be available at the same website
at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter,
YouTube and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190514005094/en/
Media: Carrie Fernandez, 609-252-5222,
carrie.fernandez@bms.comInvestors: Tim Power, 609-252-7509,
timothy.power@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
Von Mär 2023 bis Mär 2024